Thislatter study corresponds with most of the available data, suggesting that PPARγ hasantineoplastic effects in colon cancer; a point further supported in coloncancer patient studies by the detection of mutations causing loss of functionor impaired ligand binding of PPARγ [61] andpolymorphisms of the PPARγ gene [62]. The gene discussed is PPARG; the disease is malignant colon neoplasm.